Time to Stop Using the Term Relapse in Schizophrenia Clinical Trials
- PMID: 39144755
- PMCID: PMC11205881
- DOI: 10.1093/schizbullopen/sgac056
Time to Stop Using the Term Relapse in Schizophrenia Clinical Trials
Similar articles
-
Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial.Schizophr Res. 2016 Oct;176(2-3):264-271. doi: 10.1016/j.schres.2016.06.030. Epub 2016 Jul 15. Schizophr Res. 2016. PMID: 27427558 Clinical Trial.
-
Is the ongoing use of placebo in relapse-prevention clinical trials in schizophrenia justified?Schizophr Res. 2013 Nov;150(2-3):427-33. doi: 10.1016/j.schres.2013.09.008. Epub 2013 Oct 2. Schizophr Res. 2013. PMID: 24094881 Review.
-
Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review.Neuropsychiatr Dis Treat. 2016 Jan 6;12:57-67. doi: 10.2147/NDT.S96392. eCollection 2016. Neuropsychiatr Dis Treat. 2016. PMID: 26792993 Free PMC article. Review.
-
Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.Drugs. 2004;64(15):1715-36. doi: 10.2165/00003495-200464150-00010. Drugs. 2004. PMID: 15257633 Review.
-
Cost-effectiveness model of long-acting risperidone in schizophrenia in the US.Pharmacoeconomics. 2005;23(3):299-314. doi: 10.2165/00019053-200523030-00009. Pharmacoeconomics. 2005. PMID: 15836010
References
-
- Berkhout SG. Placebos in schizophrenia research: an historical overview and introduction to ethical issues. Schizophr Bull Open. 2022. Under review.
Publication types
LinkOut - more resources
Full Text Sources